Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease

The Global Biobank Meta-analysis Initiative (GBMI) unites 24 biobanks, including CanPath and its regional cohorts, with data from over 2.2 million people, to power global genetic discovery. By integrating diverse genetic info, GBMI improves disease risk prediction, advances personalized medicine, and boosts discoveries. CanPath contributes Canadian data, adding diversity and impact! Together, they’ve harmonized data, improved data on Read more about Global Biobank Meta-Analysis Initiative: How CanPath is Powering Genetic Discovery Across Human Disease[…]

CIHR Team Grants: Bringing Biology to Cancer Prevention

Team Grants — Bringing Biology to Cancer Prevention  This opportunity is led by the CIHR Institute of Cancer Research (CIHR-ICR) in collaboration with the CIHR Institutes of: Aging (CIHR-IA), Gender and Health (CIHR-IGH), Nutrition, Metabolism and Diabetes (CIHR-INMD), Population and Public Health (CIHR-IPPH), and in partnership with the BioCanRx, Canadian Cancer Society (CCS), Cancer Research Society Read more about CIHR Team Grants: Bringing Biology to Cancer Prevention[…]